Noninvasive Assessment of Liver Fibrosis in Adult Patients Following the Fontan Procedure

Congenital Heart Disease

Volumn 7, Issue 3, 2012, Pages 235-242

  Ginde, Salil ^a   Hohenwalter, Mark D ^a   Foley, W Dennis ^a   Sowinski, Jane ^a   Bartz, Peter J ^a   Venkatapuram, Suneetha ^a   Weinberg, Catherine ^a   Tweddell, James S ^a   Earing, Michael G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adult congenital heart disease; Cirrhosis; Fontan; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 2 MACROGLOBULIN; AMIODARONE; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; FONTAN PROCEDURE; HEPATITIS; HEPATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; MALE; PREVALENCE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC DYSFUNCTION; VARICOSIS;

ADULT; BIOLOGICAL MARKERS; BIOPSY; FEMALE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, SPIRAL COMPUTED; WISCONSIN; YOUNG ADULT;

EID: 84861547650     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00632.x     Document Type: Article

References (30)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240-248.
2. Khairy P, Fernandes SM, Mayer JE Jr, etal. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85-92.
3. Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol. 2007;28:438-442.
4. Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE Jr, Earing MG. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011;6:190-201.
5. Camposilvan S, Milanesi O, Stellin G, Pettenazzo A, Zancan L, D'Antiga L. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg. 2008;86:177-182.
6. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129:1348-1352.
7. Kiesewetter CH, Sheron N, Vettukattill JJ, etal. Hepatic changes in the failing Fontan circulation. Heart. 2007;93:579-584.
8. Kendall TJ, Stedman B, Hacking N, etal. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61:504-508.
9. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
10. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55:569-578.
11. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53:325-335.
12. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. the METAVIR cooperative study group. Hepatology. 1996;24:289-293.
13. Imbert-Bismut F, Ratziu V, Pieroni L, etal. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001;357:1069-1075.
14. Poynard T, Imbert-Bismut F, Ratziu V, etal. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat. 2002;9:128-133.
15. Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2007;13:525-531.
16. Naveau S, Gaude G, Asnacios A, etal. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009;49:97-105.
17. Ratziu V, Massard J, Charlotte F, etal. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:6.
18. Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273-283.
19. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47-50.
20. Taura T, Nakamura K, Takashima S, etal. Heterogeneity of hepatic parenchymal enhancement on computed tomography during arterial portography: quantitative analysis of correlation with severity of hepatic fibrosis. Hepatol Res. 2001;20:182-192.
21. Lu LG, Zeng MD, Wan MB, etal. Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol. 2003;9:2574-2578.
22. Zeitoun D, Brancatelli G, Colombat M, etal. Congenital hepatic fibrosis: CT findings in 18 adults. Radiology. 2004;231:109-116.
23. Bryant T, Ahmad Z, Millward-Sadler H, etal. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol. 2011;151:268-272.
24. Kaulitz R, Luhmer I, Bergmann F, Rodeck B, Hausdorf G. Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart. 1997;78:154-159.
25. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart. 1999;82:40-46.
26. Chaloupecky V, Svobodova I, Hadacova I, etal. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart. 2005;91:73-79.
27. Arcidi JM Jr, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol. 1981;104:159-166.
28. Myers RP, Cerini R, Sayegh R, etal. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37:393-400.
29. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947-967.
30. Saliba T, Dorkhom S, O'Reilly EM, Ludwig E, Gansukh B, Abou-Alfa GK. Hepatocellular carcinoma in two patients with cardiac cirrhosis. Eur J Gastroenterol Hepatol. 2010;22:889-891.